Search

everythinglearnresearchcommunity

for

Search:↓

Antiyeast treatments work better for seborrheic dermatitis than steroids, and other findings include increased skin bacteria under plastic wrap, a nasal cell defect in Staphylococcus aureus carriers, quick resolution of certain skin reactions, high rubber latex allergy in spina bifida patients, and glyceryl monopentadecanoate's effectiveness for male hair loss.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Patients should consult urologists for evidence-based erectile dysfunction treatments.

Different forms of hair loss drug can improve effectiveness.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Microemulsions could improve how drugs are delivered and absorbed in the body.

Young patients using finasteride may have higher risks of anxiety, depression, and suicidal thoughts.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Mesotherapy for hair loss can sometimes cause more hair loss and scarring.

Lupus nephritis patients face more challenges in family planning, work, symptoms, medication, and quality of life than those without it.

Men with hair loss feel it affects their emotions and life quality, and want more effective treatments.

Patients reduced searches for dermatology issues during COVID-19, indicating a need for better telehealth services.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Combining growth factors with minoxidil improves hair growth more than minoxidil alone.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

The workshop successfully promoted better medicine use and international collaboration.

The workshop promoted better medicine use and health practices through global collaboration.

Researchers created a skin treatment that could effectively deliver medication into hair follicles.

Transferosomes effectively deliver drugs through the skin, improving treatment for skin disorders.

Pustules in toxic erythema are linked to hair follicles or sweat ducts.

White hair follicles in vitiligo have fewer and less functional melanocytes.